Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001144204-16-111732

Options or other derivatives

  • Director acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
HILL STEPHEN A Director 2016-07-05 Grant or award · Stock option (right to buy) +22,500 $0.01 $225 25,434 D
Loading xslF345X03/v443731_4.xml…